Novogene Co., Ltd. (SHA:688315)
China flag China · Delayed Price · Currency is CNY
17.00
+1.99 (13.26%)
Jan 23, 2026, 3:00 PM CST

Novogene Statistics

Total Valuation

Novogene has a market cap or net worth of CNY 6.08 billion. The enterprise value is 4.64 billion.

Market Cap6.08B
Enterprise Value 4.64B

Important Dates

The next estimated earnings date is Wednesday, April 15, 2026.

Earnings Date Apr 15, 2026
Ex-Dividend Date Jun 10, 2025

Share Statistics

Novogene has 405.06 million shares outstanding. The number of shares has decreased by -0.11% in one year.

Current Share Class 405.06M
Shares Outstanding 405.06M
Shares Change (YoY) -0.11%
Shares Change (QoQ) -6.07%
Owned by Insiders (%) 53.05%
Owned by Institutions (%) 8.88%
Float 133.05M

Valuation Ratios

The trailing PE ratio is 34.85 and the forward PE ratio is 31.06.

PE Ratio 34.85
Forward PE 31.06
PS Ratio 2.80
PB Ratio 2.32
P/TBV Ratio 2.37
P/FCF Ratio 42.09
P/OCF Ratio 23.40
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 14.77, with an EV/FCF ratio of 32.16.

EV / Earnings 26.51
EV / Sales 2.14
EV / EBITDA 14.77
EV / EBIT 29.47
EV / FCF 32.16

Financial Position

The company has a current ratio of 2.61, with a Debt / Equity ratio of 0.03.

Current Ratio 2.61
Quick Ratio 2.15
Debt / Equity 0.03
Debt / EBITDA 0.21
Debt / FCF 0.46
Interest Coverage 97.20

Financial Efficiency

Return on equity (ROE) is 7.08% and return on invested capital (ROIC) is 12.28%.

Return on Equity (ROE) 7.08%
Return on Assets (ROA) 2.74%
Return on Invested Capital (ROIC) 12.28%
Return on Capital Employed (ROCE) 5.91%
Revenue Per Employee 986,773
Profits Per Employee 79,569
Employee Count2,190
Asset Turnover 0.60
Inventory Turnover 5.53

Taxes

In the past 12 months, Novogene has paid 17.85 million in taxes.

Income Tax 17.85M
Effective Tax Rate 9.04%

Stock Price Statistics

The stock price has increased by +27.53% in the last 52 weeks. The beta is 0.75, so Novogene's price volatility has been lower than the market average.

Beta (5Y) 0.75
52-Week Price Change +27.53%
50-Day Moving Average 14.05
200-Day Moving Average 14.63
Relative Strength Index (RSI) 57.29
Average Volume (20 Days) 6,531,355

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, Novogene had revenue of CNY 2.17 billion and earned 175.21 million in profits. Earnings per share was 0.43.

Revenue2.17B
Gross Profit 932.20M
Operating Income 157.63M
Pretax Income 197.45M
Net Income 175.21M
EBITDA 294.04M
EBIT 157.63M
Earnings Per Share (EPS) 0.43
Full Income Statement

Balance Sheet

The company has 1.53 billion in cash and 66.17 million in debt, with a net cash position of 1.46 billion or 3.61 per share.

Cash & Cash Equivalents 1.53B
Total Debt 66.17M
Net Cash 1.46B
Net Cash Per Share 3.61
Equity (Book Value) 2.62B
Book Value Per Share 6.41
Working Capital 1.67B
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 259.82 million and capital expenditures -115.38 million, giving a free cash flow of 144.44 million.

Operating Cash Flow 259.82M
Capital Expenditures -115.38M
Free Cash Flow 144.44M
FCF Per Share 0.36
Full Cash Flow Statement

Margins

Gross margin is 42.90%, with operating and profit margins of 7.25% and 8.06%.

Gross Margin 42.90%
Operating Margin 7.25%
Pretax Margin 9.09%
Profit Margin 8.06%
EBITDA Margin 13.53%
EBIT Margin 7.25%
FCF Margin 6.65%

Dividends & Yields

This stock pays an annual dividend of 0.05, which amounts to a dividend yield of 0.33%.

Dividend Per Share 0.05
Dividend Yield 0.33%
Dividend Growth (YoY) 5.26%
Years of Dividend Growth 2
Payout Ratio 11.56%
Buyback Yield 0.11%
Shareholder Yield 0.44%
Earnings Yield 2.88%
FCF Yield 2.38%
Dividend Details

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Novogene has an Altman Z-Score of 4.95 and a Piotroski F-Score of 6.

Altman Z-Score 4.95
Piotroski F-Score 6